RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.56B
AUM Growth
-$299M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
87
New
Increased
Reduced
Closed

Top Buys

1
+$130M
2
+$115M
3
+$88.5M
4
RNA icon
Avidity Biosciences
RNA
+$86.5M
5
BIIB icon
Biogen
BIIB
+$56M

Top Sells

1
+$91.9M
2
+$54.6M
3
+$45.7M
4
VXRT
Vaxart
VXRT
+$20M
5
EYPT icon
EyePoint Pharmaceuticals
EYPT
+$19.4M

Sector Composition

1 Healthcare 99.86%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.38B 18.23%
10,108,400
2
$619M 8.19%
8,203,754
3
$384M 5.08%
9,165,652
4
$332M 4.4%
7,506,934
+645,837
5
$250M 3.3%
6,084,412
+754,000
6
$228M 3.01%
982,139
+241,412
7
$223M 2.95%
31,419,267
+18,268,418
8
$222M 2.94%
3,694,825
+252,000
9
$221M 2.92%
5,400,408
+2,118,228
10
$213M 2.82%
6,049,204
+1,094,425
11
$196M 2.59%
46,202,425
12
$171M 2.26%
10,689,545
13
$167M 2.2%
10,416,609
14
$163M 2.15%
8,514,862
+2,778,730
15
$160M 2.12%
8,909,091
16
$155M 2.05%
8,064,000
+200,000
17
$115M 1.53%
+15,384,615
18
$114M 1.5%
14,175,398
+1,408,450
19
$110M 1.46%
7,632,646
+1,314,656
20
$108M 1.43%
7,871,721
+61,869
21
$107M 1.42%
5,098,211
+46,700
22
$92.4M 1.22%
10,860,977
23
$90.8M 1.2%
18,202,009
24
$88.9M 1.18%
3,289,119
25
$88.5M 1.17%
+1,604,014
1
2 3 4